Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium

Journal of Clinical Microbiology

Volumn 35, Issue 3, 1997, Pages 614-619

  Henry, D A ^a   Campbell, M E ^a   LiPuma, J J ^b   Speert, D P ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CULTURE MEDIUM; CYSTIC FIBROSIS; NONHUMAN; PRIORITY JOURNAL;

ACHROMOBACTER XYLOSOXIDANS; ALCALIGENES; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; COMAMONAS; DELFTIA ACIDOVORANS; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031050491     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.3.614-619.1997     Document Type: Article

References (20)

1. Burdge, D. R., M. A. Noble, M. E. Campbell, V. L. Krell, and D. P. Speert. 1994. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20:445-448.
2. Campbell, P. W., J. A. Phillips, G. J. Heidecker, M. R. S. Krishnamani, R. Zahorchak, and T. L. Stull. 1995. Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr. Pulmonol. 20:44-49.
3. Christenson, J. C., D. F. Welch, G. Mukwaya, M. J. Muszynski, R. E. Weaver, and D. J. Brenner. 1989. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J. Clin. Microbiol. 27:270-273.
4. Clark, W. A. 1976. A simplified Leifson flagella stain. J. Clin. Microbiol. 3:632-634.
5. Clinic Subcommittee, Canadian Cystic Fibrosis Foundation. 1993. Microbiological processing of respiratory specimens from patients with cystic fibrosis. Can. J. Infect. Dis. 4:166-169.
6. Gilardi, G. L. 1985. Pseudomonas. p. 350-372. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
7. Gilligan, P. H., P. A. Gage, L. M. Bradshaw, D. V. Schidlow, and B. T. DeCicco. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 22:5-8.
8. Gilligan, P. H. 1995. Pseudomonas and Burkholderia, p. 509-519. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
9. Govan, J. R. W., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
10. Henry, D. A., M. E. Campbell, and D. P. Speert. 1995. Proceedings of the Ninth North American Cystic Fibrosis Conference, abstr. 249.
11. Hugh, R., and E. Leifson. 1953. The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram-negative bacteria. J. Bacteriol. 66:24-26.
12. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
13. LiPuma, J. L., K. A. Marks-Austin, D. S. Holsclaw, G. B. Winnie, P. H. Gilligan, and T. L. Stull. 1994. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr. Infect. Dis. J. 13:716-719.
14. Mahenthiralingam, E., M. E. Campbell, D. A. Henry, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
15. Speert, D. P., and the Clinic Subcommittee, Canadian Cystic Fibrosis Foundation. 1993. Epidemiology of Pseudomonas cepacia in cystic fibrosis. Can. J. Infect. Dis. 4:163-165.
16. Steers, E., E. L. Foltz, and B. S. Graves. 1959. An inocula replicating apparatus for routine testing of bacterial susceptibility testing to antibiotics. Antibiot. Chemother. 9:307-311.
17. Stull, T. L., J. J. LiPuma, and T. D. Edlind. 1988. A broad-spectrum probe for molecular epidemiology of bacteria. J. Infect. Dis. 157:280-286.
18. Tablan, O. C., L. A. Carson, L. B. Cusick, L. A. Bland, W. J. Martone, and W. R. Jarvis. 1987. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J. Clin. Microbiol. 25:485-487.
19. von Graevenitz, A. 1995. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria, p. 520-532. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
20. Welch, D. F., M. J. Muszynski, C. H. Pai, M. J. Maracon, M. M. Hribar, P. H. Gilligan, J. M. Matsen, P. A. Ahlin, B. C. Hilman, and S. A. Chartrand. 1987. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J. Clin. Microbiol. 25:1730-1734.